Skip to content
Biodatica
Start free

Investigator

Joseph Moeketsi Makhema

THE BOTSWANA HARVARD HEALTH PARTNERSHIP · funded by NIAID, FIC

Companies
3

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$3.4M

Summed across those awards.

First award
Feb 1, 2007

Latest Feb 20, 2018.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. U01

    A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana

    $646k

    Feb 20, 2018NIAIDTHE BOTSWANA HARVARD HEALTH PARTNERSHIPNIH RePORTER · 11415443 (opens the source filing in a new tab)

  2. D43

    Training in HIV Genomics, Treatment, and Cure Research in Botswana

    $302k

    Aug 1, 2013FICTHE BOTSWANA HARVARD HEALTH PARTNERSHIPNIH RePORTER · 11335304 (opens the source filing in a new tab)

  3. D43

    Training in HIV Genomics, Treatment, and Cure Research in Botswana

    $301k

    Aug 1, 2013FICTHE BOTSWANA HARVARD HEALTH PARTNERSHIPNIH RePORTER · 11355633 (opens the source filing in a new tab)

  4. UM1

    Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU

    $2.1M

    Feb 1, 2007NIAIDTHE BOTSWANA HARVARD HEALTH PARTNERSHIPNIH RePORTER · 11412843 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources